AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Biomarker for CRC Screening

Summary

Colorectal cancer (CRC) is the second most common cause for cancer-related death worldwide. Lifetime risk of CRC is approximately 6% and of colorectal adenoma approximately 50%. Early detection and removal of adenoma has been shown to reduce the incidence and mortality of CRC. Colonoscopy remains to be the gold standard for detecting CRC and pre-malignant adenomas. However, this procedure is costly, labor intensive and uncomfortable. We have developed a new screening tool based on detecting tumor derived molecular changes in stool. This test provides a non-invasive means for detecting CRC.

Application No.

10/MED/349

Others

Inventor(s): Professor Joseph SUNG, Department of Medicine and Therapeutics

Patent Status: US Patent Pending Licensing Status: Available for licensing

Country/Region

Hong Kong

For more information, please click Here